Related references
Note: Only part of the references are listed.Human colorectal cancer cells frequently express IgG and display unique Ig repertoire
Zi-Han Geng et al.
WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY (2019)
Integrated Biobanking and Tumor Model Establishment of Human Colorectal Carcinoma Provides Excellent Tools for Preclinical Research
Christina S. Mullins et al.
CANCERS (2019)
LW6 enhances chemosensitivity to gemcitabine and inhibits autophagic flux in pancreatic cancer
Xianbin Zhang et al.
JOURNAL OF ADVANCED RESEARCH (2019)
Pharmacological Targeting of Cell Cycle, Apoptotic and Cell Adhesion Signaling Pathways Implicated in Chemoresistance of Cancer Cells
Dauren Alimbetov et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Consensus molecular subtypes classification of colorectal cancer as a predictive factor for chemotherapeutic efficacy against metastatic colorectal cancer
Akira Okita et al.
Oncotarget (2018)
Role of Reactive Oxygen Species in the Abrogation of Oxaliplatin Activity by Cetuximab in Colorectal Cancer
Valeria Santoro et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
Role of Reactive Oxygen Species in the Abrogation of Oxaliplatin Activity by Cetuximab in Colorectal Cancer
Valeria Santoro et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
Association Between Molecular Subtypes of Colorectal Cancer and Patient Survival
Amanda I. Phipps et al.
GASTROENTEROLOGY (2015)
Allogeneic IgG combined with dendritic cell stimuli induce antitumour T-cell immunity
Yaron Carmi et al.
NATURE (2015)
Aberrant high expression of immunoglobulin G in epithelial stem/progenitor-like cells contributes to tumor initiation and metastasis
Qinyuan Liao et al.
ONCOTARGET (2015)
Reconciliation of classification systems defining molecular subtypes of colorectal cancer
Anguraj Sadanandam et al.
CELL CYCLE (2014)
Physician-Patient Communication Regarding Colorectal Cancer Screening Is Lacking
Mary Kay Barton
CA-A CANCER JOURNAL FOR CLINICIANS (2012)
Chemoprevention, chemotherapy, and chemoresistance in colorectal cancer
Jose J. G. Marin et al.
DRUG METABOLISM REVIEWS (2012)
IgG Expression in Human Colorectal Cancer and Its Relationship to Cancer Cell Behaviors
Na Niu et al.
PLOS ONE (2012)
Oxaliplatin: a review in the era of molecularly targeted therapy
T. Alcindor et al.
Current Oncology (2011)
Oxaliplatin As Adjuvant Therapy for Colon Cancer: Updated Results of NSABP C-07 Trial, Including Survival and Subset Analyses
Greg Yothers et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Check your cultures! A list of cross-contaminated or misidentified cell lines
Amanda Capes-Davis et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
An ERK-dependent pathway to Noxa expression regulates apoptosis by platinum-based chemotherapeutic drugs
C. Sheridan et al.
ONCOGENE (2010)
Oncogenic B-RafV600E inhibits apoptosis and promotes ERK-dependent inactivation of Bad and Bim
Clare Sheridan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
The costs of using unauthenticated, over-passaged cell lines: how much more data do we need?
Peyton Hughes et al.
BIOTECHNIQUES (2007)
Current status of excision repair cross complementing-group 1 (ERCC1) in cancer
Lucy Gossage et al.
CANCER TREATMENT REVIEWS (2007)
p53 regulates ERK activation in carboplatin induced apoptosis in cervical carcinoma: A novel target of p53 in apoptosis
Sandeep Singh et al.
FEBS LETTERS (2007)
Cisplatin-induced apoptosis in human malignant testicular germ cell lines depends on MEK/ERK activation
S Schweyer et al.
BRITISH JOURNAL OF CANCER (2004)
Oncogenic H-ras up-regulates expression of ERCCI to protect cells from platinum-based anticancer agents
CK Youn et al.
CANCER RESEARCH (2004)
Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer
T Andre et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Cl-1040 (PD184352), a targeted signal transduction inhibitor of MEK (MAPKK)
LF Allen et al.
SEMINARS IN ONCOLOGY (2003)
Activation of the ERK1/2 signaling pathway promotes phosphorylation and proteasome-dependent degradation of the BH3-only protein, Bim
R Ley et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: Report of the BIOMED-2 Concerted Action BMH4-CT98-3936
JJM van Dongen et al.
LEUKEMIA (2003)
ERCC1 and thymidylate synthase mRNA levels predict survival for colorectal cancer patients receiving combination oxaliplatin and fluorouracil chemotherapy
Y Shirota et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Integrating oxaliplatin into the management of colorectal cancer
HJ Schmoll et al.
ONCOLOGIST (2001)
Requirement for ERK activation in cisplatin-induced apoptosis
XT Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
